Product Wiki · Recalls · EU Safety Gate (RAPEX)

Kaulakoru — recall A12/0417/19

EU Safety Gate (RAPEX) · Finland · 2019-03-15 · Serious risk

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Agency
EU Safety Gate (RAPEX)
Recall identifier
A12/0417/19
Date of alert
2019-03-15
Country / jurisdiction
Finland
Risk level
Serious risk
Risk type
Chemical
Brand
Unknown
Product category
Jewellery
Product type
Necklace
Reported risk: Kädenmuotoisen riipuksen metalli sisältää liikaa kadmiumia (mitattu arvo: 50 painoprosenttia). Kadmium on haitallista ihmisten terveydelle, koska se kertyy elimistöön, voi vahingoittaa elimiä ja voi aiheuttaa syöpää. Tuote ei täytä REACH-asetuksen vaatimuksia.
Machine translation. This notice was published in English by the issuing authority and translated automatically. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.

Product Name (original English): Necklace

Risk Description (original English): The metal of the hand-shaped pendant contains an excessive amount of cadmium (measured value: 50 % by weight). Cadmium is harmful to human health because it accumulates in the body, can damage organs and it may cause cancer.The product does not comply with the REACH Regulation.

Measures (original English): Type of economic operator to whom the measure(s) were ordered: ImporterCategory of measure(s): Import rejected at borderDate of entry into force: 25/02/2019

Primary source: https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/357632

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

Related

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.